Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MJardin Group Inc MJARF

MJardin Group is a cannabis management platform with extensive experience in cultivation, processing, distribution, and retail. For over 10 years, MJardin Group has refined cultivation methodologies, developed state of the art facilities, and implemented vertical integration for and on behalf of license owners. MJardin Group currently owns, manages or advises on a portfolio of 32 cannabis... see more

GREY:MJARF - Post Discussion

MJardin Group Inc > Financials
View:
Post by Nevergiveup9 on Nov 05, 2020 9:43am

Financials

Q3 released.

 

ORIGINAL: MJardin Group Announces Third Quarter 2020 Financial Results

2020-11-05 08:00 ET - News Release

  • Continued stabilization of the business with steadfast focus on cost management, and production maximization to drive revenue and margin growth
  • Continued revenue growth expected in Q4 2020

DENVER and TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced its financial and operating results for its third quarter ended September 30, 2020. All amounts are expressed in Canadian dollars unless otherwise indicated.

Q3 Highlights:

  • The Company has been able to grow a new fifth strain testing at 24% THC on behalf of Robes at its WILL facility (“WILL”);
  • All harvests out of the WILL and GRO facilities (“GRO”) have passed HC microbial testing without the use of irradiation treatment;
  • Revenue amounted to $4.8 million;
  • Adjusted EBITDA loss of $1.4 million;
  • Net income of $7.2 million;
  • AtlantiCann Medical Inc. (“AMI”) joint venture contributed $3.1 million to earnings, an increase of approximately 140% from the prior quarter, as shown on net earnings from equity investment line in the financial statements;
  • Completed first wholesale transaction following completion of construction at all Ontario facilities;
  • Completed construction and licensing of final two flower rooms at the Company’s WILL cultivation facility located in Brampton, Ontario;
  • Entered into master service agreement with the Ontario Cannabis Store (“OCS”) for cannabis cultivated at WILL;
  • 138% increase in quarter-over-quarter flower production at the Company’s GRO cultivation facility located in Dunnville, Ontario;
  • In anticipation of launching retail products in Q4 2020, the Company has transitioned away from previously announced wholesale agreements.

“We continue to work diligently to complete our asset optimization initiatives to drive continued revenue growth objectives. Our operational and financial performance during the quarter continues to validate our team’s efforts as we report a third consecutive quarter of stable operations,” commented Pat Witcher, CEO of MJardin. “We continue to explore strategic opportunities with the potential to complement our organic growth profile while ultimately creating shareholder value. We remain confident in the prospects for our business, and look forward to sharing our success with our shareholders as we execute our turnaround plan.”

Be the first to comment on this post